381
Views
13
CrossRef citations to date
0
Altmetric
Inflammatory Bowel Disease

Adalimumab treatment in Crohn's disease does not induce early changes in regulatory T cells

, , , , , & show all
Pages 1206-1214 | Received 08 Mar 2011, Accepted 20 Jun 2011, Published online: 27 Jul 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Christian L. Hvas, Mia Bendix, Anders Dige, Jens F. Dahlerup & Jørgen Agnholt. (2018) Current, experimental, and future treatments in inflammatory bowel disease: a clinical review. Immunopharmacology and Immunotoxicology 40:6, pages 446-460.
Read now

Articles from other publishers (12)

Mobina Jalalvand, Samaneh Enayati, Maryam Akhtari, Elham Madreseh, Ahmadreza Jamshidi, Elham Farhadi, Mahdi Mahmoudi & Aliakbar Amirzargar. (2023) Blood regulatory T cells in inflammatory bowel disease, a systematic review, and meta-analysis. International Immunopharmacology 117, pages 109824.
Crossref
Yaoyao Chang, Lixiang Zhai, Jiao Peng, Haiqiang Wu, Zhaoxiang Bian & Haitao Xiao. (2021) Phytochemicals as regulators of Th17/Treg balance in inflammatory bowel diseases. Biomedicine & Pharmacotherapy 141, pages 111931.
Crossref
Benoit L. Salomon. (2021) Insights into the biology and therapeutic implications of TNF and regulatory T cells. Nature Reviews Rheumatology 17:8, pages 487-504.
Crossref
A. Dige, T. K. Rasmussen, P. Nejsum, R. Hagemann-Madsen, A. R. Williams, J. Agnholt, J. F. Dahlerup & C. L. Hvas. (2017) Mucosal and systemic immune modulation by Trichuris trichiura in a self-infected individual . Parasite Immunology 39:1, pages e12394.
Crossref
Christophe Pedros. (2016) Disrupted regulatory T cell homeostasis in inflammatory bowel diseases. World Journal of Gastroenterology 22:3, pages 974.
Crossref
A. Dige, S. Støy, K. L. Thomsen, C. L. Hvas, J. Agnholt, J. F. Dahlerup, H. J. Møller & H. Grønbaek. (2014) Soluble CD163, a Specific Macrophage Activation Marker, is Decreased by Anti-TNF- α Antibody Treatment in Active Inflammatory Bowel Disease . Scandinavian Journal of Immunology 80:6, pages 417-423.
Crossref
Maria K Magnusson, Rahil Dahlén, Hans Strid, Stefan Isaksson, Magnus Simrén, Anders Lasson, Antal Bajor, Kjell‐Arne Ung & Lena Öhman. (2013) CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis. United European Gastroenterology Journal 1:6, pages 467-476.
Crossref
David J. Gibson, Elizabeth J. Ryan & Glen A. Doherty. (2013) Keeping the Bowel Regular. Inflammatory Bowel Diseases 19:12, pages 2716-2724.
Crossref
R. Dahlén, H. Strid, A. Lundgren, S. Isaksson, S. Raghavan, M. K. Magnusson, M. Simrén, H. Sjövall & L. Öhman. (2013) Infliximab Inhibits Activation and Effector Functions of Peripheral Blood T Cells in vitro from Patients with Clinically Active Ulcerative Colitis . Scandinavian Journal of Immunology 78:3, pages 275-284.
Crossref
L. Rebekka Ryder, Lars P. Ryder, Else M. Bartels, Anders Woetmann, Hans O. Madsen, Niels Ødum, Bente Danneskiold‐Samsøe, Søren Ribel‐Madsen & Henning Bliddal. (2012) Differential effects of decoy receptor‐ and antibody‐mediated tumour necrosis factor blockage on FoxP3 expression in responsive arthritis patients . APMIS 121:4, pages 337-347.
Crossref
Luisa Guidi, Carla Felice, Annabella Procoli, Giuseppina Bonanno, Enrica Martinelli, Manuela Marzo, Giammarco Mocci, Daniela Pugliese, Gianluca Andrisani, Silvio Danese, Italo De Vitis, Alfredo Papa, Alessandro Armuzzi & Sergio Rutella. (2013) FOXP3 + T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNF Agents . BioMed Research International 2013, pages 1-10.
Crossref
Anne M. Pesenacker & Lucy R. Wedderburn. (2013) T regulatory cells in childhood arthritis – novel insights. Expert Reviews in Molecular Medicine 15.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.